Mechanical Circulatory Support Devices - Medical Devices Pipeline Assessment, 2019
December 2019
264
About the Report
About the Report
Mechanical Circulatory Support Devices-Medical Devices Pipeline Assessment, 2019
Summary
GlobalData's Medical Devices sector report, Mechanical Circulatory Support Devices-Medical Devices Pipeline Assessment, 2019" provides an overview of Mechanical Circulatory Support Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Mechanical Circulatory Support Devices pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Mechanical Circulatory Support Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Mechanical Circulatory Support Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Mechanical Circulatory Support Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
Abiomed Inc, AbioCor II, Heart Failure; Abiomed Inc, Impella BTR, Heart Failure; Abiomed Inc, Impella ECP, Heart Failure; Abiomed Inc, Next Generation Impella CP - STEMI, ST Segment Elevation Myocardial Infarction; Arrow International Cr, A.S., CorAide Left Ventricular Assist System, Ventricular Arrhythmia; BioVentrix Inc, PliCath HF, Cardiomyopathy; BiVacor Pty Ltd, BiVACOR Device, MAGLEV Technology, Heart Failure; Braile Biomedica Ltda, Blood Pump, Heart Failure; Calon Cardio-Technology Ltd, Calon MiniVAD, Chronic Heart Failure; Calon Cardio-Technology Ltd, CathVAD, Heart Failure; Calon Cardio-Technology Ltd, MicroVAD, Heart Failure; CardiacAssist Inc, Pediatric pVAD, Heart Failure; CARDIAnove Inc, CARDIAnove Pump, Heart Failure; Carmat SAS, Artificial Heart, End-Stage Heart Failure; Carnegie Mellon University, Non-Blood Contacting Muscle Powered VAD, Congestive Heart Failure; Carnegie Mellon University, tVAD - Heart Failure, Heart Failure; Cleveland Clinic Hospital, PediPump, Heart Failure; Cleveland Clinic Lerner College of Medicine, Continuous-Flow Total Artificial Heart, Heart Failure; Cleveland Clinic Lerner College of Medicine, Pediatric Continuous-Flow Total Artificial Heart, Heart Failure; Cleveland Heart Inc, SmartHeart LVAD, Heart Failure; Cleveland Heart Inc, SmartHeart TAH, Heart Failure; CorAssist Cardiovascular Ltd, CORolla, Diastolic Heart Failure; CorAssist Cardiovascular Ltd, ImCardia, Heart Failure; Corinnova Inc, CardiacSTAR - Bridge To Decision, Heart Failure; Corinnova Inc, CardiacSTAR - Bridge To Recovery, Heart Failure; Corinnova Inc, CardiacSTAR - Bridge To Transplant, Heart Failure; Corinnova Inc, CardiacSTAR - Destination Therapy, Heart Failure; Corinnova Inc, CardiacSTAR - Heart Rehabilitation, Heart Failure; Corinnova Inc, EpicHeart - Soft Robotic Heart Device, End-Stage Heart Failure; CorWave, CorWave Nemo, Tubular Membrane Technology, Heart Failure; CorWave, CorWave Neptune, Disc Membrane Technology, Heart Failure; Drexel University, Intravascular Blood Pump, Congenital Heart Disease; Duke University, Para-Aortic Blood Pump, Heart Failure; Ension, Inc., CardioFlowPQ, Heart Failure; Evaheart Inc, EVAHEART Left Ventricular Assist System, Heart Failure; Evaheart Inc, EVAHEART Left Ventricular Assist System, Ventricular Arrhythmia; Everheart Systems, LLC, Fully Implantable Left Ventricular Assist Device, Heart Failure; FineHeart, ICOMS, Heart Failure; Foster-Miller Inc (Inactive), MagScrew Total Artificial Heart, Heart Failure; Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon, Ventricular Assist Device, Heart Failure; Georgia Institute of Technology, OptiFlo, Single Ventricle Heart Defect; Grupo Vitalmex SA de CV, Vitacor-UVAD, Heart Failure; Harvard University, Soft Robotic Sleeve, Heart Failure; HeartWare International Inc, BiVAD, Impeller Suspension Technology , Heart Failure; HeartWare International Inc, HeartWare IV-VAD, Heart Failure; HeartWare International Inc, HVAD System - Destination Therapy, Impeller Suspension Technology , Heart Failure; HeartWare International Inc, Levacor Rotary VAD, Magnetic Levitation (Mag-Lev) Technology, Heart Failure; HeartWare International Inc, Longhorn, Impeller Suspension Technology , Heart Failure; HeartWare International Inc, MiFlow VAD, MAGLEV Technology, Heart Failure; HeartWare International Inc, Miniaturized Ventricular Assist Device (MVAD) Pump, Impeller Suspension Technology , Heart Failure; HeartWare International Inc, VCAN Trans-Mitral, Impeller Suspension Technology , Heart Failure; I.M. Sechenov Moscow State Medical University, Cardiac Assist Device - Children, Cardiomyopathy; Indian Institute of Technology Kharagpur, Artificial Heart, Heart Failure; Indiana University, Bi-Conical Heart Pump, Single Ventricle Heart Defect; Inspired Therapeutics LLC, INSPIRE System, Cardiopulmonary Diseases; Jarvik Heart Inc, Jarvik 2000 Heart - Bridge To Transplant, Heart Failure; Jarvik Heart Inc, Jarvik 2000 Heart - Destination Therapy, Heart Failure; Jarvik Heart Inc, Jarvik 2015, Heart Failure; LaunchPoint Technologies, Inc., Pediaflow Pediatric VAD, Magnetic Levitation (Mag-Lev) Technology, Congenital Heart Disease; LaunchPoint Technologies, Inc., Streamliner VAD, Heart Failure; Lausanne University Hospital, RollingHeart, Heart Failure; Leviticus Cardio Ltd, FiVAD System, Heart Failure; Leviticus Cardio Ltd, Hybrid FILVAS, Heart Failure; Levram Medical Systems Ltd, LEVRAM-Ventricular Assist Device, Congestive Heart Failure; Mayo Clinic, Device For Diastolic Heart Failure, Diastolic Heart Failure; Mayo Clinic, Implantable Left Ventricular Assist Device, Heart Failure; Medtronic plc, Fully Implantable Left Ventricular Assist Device, Heart Failure; Michigan Critical Care Consultants, Inc., pediatric MPulse, Cardiovascular Diseases; MyoCardioCare, Inc., MCC3000 Heart Pump - Pediatrics, Direct Mechanical Ventricular Actuation Technology, Cardiac Arrest; MyoCardioCare, Inc., MCC3000 Heart Pump, Direct Mechanical Ventricular Actuation Technology, Cardiac Arrest; Myotech, LLC (Inactive), Myotech Circulatory Support System, Direct Mechanical Ventricular Actuation Technology, Heart Failure; NeoCardial Technologies, LLC, eHeart Extra Ventricular Assist Device, Congestive Heart Failure; Nipro Corp, BR16010, Cardiogenic Shock ; Nipro Corp, BR16010, Heart Failure; Nipro Corp, Implantable Ventricular Assist Device, Heart Failure; Novapump GmbH, PERKAT Biventricular Heart Pump, Heart Failure; Novapump GmbH, PERKAT RV, Heart Failure; NuPulseCV, NuPulseCV iVAS, Chronic Heart Failure; OregonHeart Inc (Inactive), Next Generation Total Artificial Heart, Heart Failure; Pennsylvania State University, Pediatric Heart-Assist Device, Heart Failure; Perfusion Solution Inc, Cavopulmonary Assist System, Single Ventricle Heart Defect; Perfusion Solution Inc, Right Ventricular Assist Device - Long Term Care, Right Ventricular Failure; Perfusion Solution Inc, Transapical LVAD, Single Ventricle Heart Defect; PlugMed Heart SAS, Implantable Left Ventricular Assist Device, Heart Failure; Procyrion Inc, Aortix Device, Transcutaneous Energy Transfer (TET) Technology, Heart Failure; Purdue University, Viscous Impeller Pump - Infants, Congenital Heart Disease; ReliantHeart, Inc., aVAD Liberty System, Heart Failure; ReliantHeart, Inc., aVAD, Heart Failure; ReliantHeart, Inc., Pulse Less Total Artificial Heart, Heart Failure; Rutgers The State University of New Jersey, Temporary Percutaneous Ventricular Assist Device, Cardiogenic Shock ; Rutgers The State University of New Jersey, Temporary Percutaneous Ventricular Assist Device, Cardiovascular Diseases; Rutgers The State University of New Jersey, Temporary Percutaneous Ventricular Assist Device, Right Ventricular Failure; Rutgers The State University of New Jersey, Temporary Percutaneous Ventricular Assist Device, Tachycardia; Rutgers The State University of New Jersey, Temporary Percutaneous Ventricular Assist Device, Ventricular Arrhythmia; Scandinavian Real Heart AB, Total Artificial Heart, Heart Failure; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Paracorporeal Left Ventricle Assist Device, Heart Failure; St. Jude Medical LLC, UltraMag Adult Ventricular Assist System, Magnetically Levitated Technology, Heart Failure; St. Jude Medical LLC, UltraMag Pediatric Ventricular Assist System, Magnetically Levitated Technology, Heart Failure; Sunshine Heart Company, Pty. Ltd., C-Pulse - Wireless Version, Balloon Counterpulsation Technology, Heart Failure; Syncardia Systems LLC, 10cc Ventricular Assist Device, Heart Failure; Syncardia Systems LLC, 30cc Ventricular Assist Device, Heart Failure; Syncardia Systems LLC, 60cc Ventricular Assist Device, Heart Failure; Syncardia Systems LLC, SynCardia 50cc Temporary Total Artificial Heart - Adult Bridge To Transplant, End-Stage Heart Failure; Syncardia Systems LLC, SynCardia 50cc Temporary Total Artificial Heart - Destination Therapy, End-Stage Heart Failure; Syncardia Systems LLC, SynCardia 50cc Temporary Total Artificial Heart - Pediatric Bridge To Transplant, End-Stage Heart Failure; Syncardia Systems LLC, SynCardia 70cc Temporary Total Artificial Heart - Destination Therapy, End-Stage Heart Failure; TEDA International Cardiovascular Hospital, Artificial Heart, Heart Failure; Terumo Corp, DuraHeart Destination Therapy Left Ventricular Assist System, Heart Failure; The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development, ReligaHeart EXT, DSM’s SAME Technology, Heart Failure; Thoratec Corp, DuraHeart II, Heart Failure; Thoratec Corp, Fully Implantable Ventricular Assist System, Heart Failure; Thoratec Corp, HeartMate X, Magnetically Levitated Technology, Heart Failure; Tokyo Medical and Dental University, TinyPump, Heart Failure; U.S. Stem Cell Inc, SVAD, Heart Failure; University of Louisville, Paediatric Heart Pump, Single Ventricle Heart Defect; University of Michigan, BioVAD, Cardiogenic Shock ; University of Michigan, BioVAD, End-Stage Heart Failure; University of Tokyo, Helical Flow Total Artificial Heart, Heart Failure; University of Virginia, VADStent, Chronic Heart Failure; Vadovations, Inc., REVOLUTION, Congestive Heart Failure; VASCOR Inc, Vascor LVAD, Heart Failure; Windmill Cardiovascular Systems, Inc., TORVAD, Heart Failure; Yale University, BoLetz Pump, Heart Failure; Yale University, CAP RVAD Pump, Heart Failure; Yale University, Corisma, Heart Failure
Companies
Abiomed Inc
Arrow International Cr, A.S.
BioVentrix Inc
BiVacor Pty Ltd
Braile Biomedica Ltda
Calon Cardio-Technology Ltd
CardiacAssist Inc
CARDIAnove Inc
Carmat SAS
Carnegie Mellon University
Cleveland Clinic Hospital
Cleveland Clinic Lerner College of Medicine
Cleveland Heart Inc
CorAssist Cardiovascular Ltd
Corinnova Inc
CorWave
Drexel University
Duke University
Ension, Inc.
Evaheart Inc
Everheart Systems, LLC
FineHeart
Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
Georgia Institute of Technology
Grupo Vitalmex SA de CV
Harvard University
HeartWare International Inc
I.M. Sechenov Moscow State Medical University
Indian Institute of Technology Kharagpur
Indiana University
Inspired Therapeutics LLC
Jarvik Heart Inc
LaunchPoint Technologies, Inc.
Lausanne University Hospital
Leviticus Cardio Ltd
Levram Medical Systems Ltd
Mayo Clinic
Medtronic plc
Michigan Critical Care Consultants, Inc.
MyoCardioCare, Inc.
NeoCardial Technologies, LLC
Nipro Corp
Novapump GmbH
NuPulseCV
Pennsylvania State University
Perfusion Solution Inc
PlugMed Heart SAS
Procyrion Inc
Purdue University
ReliantHeart, Inc.
Rutgers The State University of New Jersey
Scandinavian Real Heart AB
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Sunshine Heart Company, Pty. Ltd.
Syncardia Systems LLC
TEDA International Cardiovascular Hospital
Terumo Corp
The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development
Thoratec Corp
Tokyo Medical and Dental University
U.S. Stem Cell Inc
University of Louisville
University of Michigan
University of Tokyo
University of Virginia
Vadovations, Inc.
VASCOR Inc
Windmill Cardiovascular Systems, Inc.
Yale University
Table of Contents
Table of Contents
Table of Contents
1.1 List of Tables 8
1.2 List of Figures 14
2 Introduction 15
2.1 Mechanical Circulatory Support Devices Overview 15
3 Products under Development 16
3.1 Mechanical Circulatory Support Devices-Pipeline Products by Stage of Development 16
3.2 Mechanical Circulatory Support Devices-Pipeline Products by Segment 17
3.3 Mechanical Circulatory Support Devices-Pipeline Products by Territory 18
3.4 Mechanical Circulatory Support Devices-Pipeline Products by Regulatory Path 19
3.5 Mechanical Circulatory Support Devices-Pipeline Products by Estimated Approval Date 20
3.6 Mechanical Circulatory Support Devices-Ongoing Clinical Trials 21
4 Mechanical Circulatory Support Devices-Pipeline Products under Development by Companies 22
4.1 Mechanical Circulatory Support Devices Companies-Pipeline Products by Stage of Development 22
4.2 Mechanical Circulatory Support Devices-Pipeline Products by Stage of Development 25
5 Mechanical Circulatory Support Devices Companies and Product Overview 29
5.1 Abiomed Inc Company Overview 29
5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Arrow International Cr, A.S. Company Overview 35
5.2.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 BioVentrix Inc Company Overview 36
5.3.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 BiVacor Pty Ltd Company Overview 39
5.4.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
5.5 Braile Biomedica Ltda Company Overview 40
5.5.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 Calon Cardio-Technology Ltd Company Overview 41
5.6.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
5.7 CardiacAssist Inc Company Overview 44
5.7.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.8 CARDIAnove Inc Company Overview 45
5.8.1 CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.9 Carmat SAS Company Overview 46
5.9.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 Carnegie Mellon University Company Overview 50
5.10.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 50
5.11 Cleveland Clinic Hospital Company Overview 52
5.11.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 Cleveland Clinic Lerner College of Medicine Company Overview 53
5.12.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Cleveland Heart Inc Company Overview 55
5.13.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 CorAssist Cardiovascular Ltd Company Overview 57
5.14.1 CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 57
5.15 Corinnova Inc Company Overview 61
5.15.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 61
5.16 CorWave Company Overview 66
5.16.1 CorWave Pipeline Products & Ongoing Clinical Trials Overview 66
5.17 Drexel University Company Overview 68
5.17.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 Duke University Company Overview 69
5.18.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Ension, Inc. Company Overview 70
5.19.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 Evaheart Inc Company Overview 71
5.20.1 Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 71
6 Mechanical Circulatory Support Devices- Recent Developments 170
6.1 Nov 27, 2019: CARMAT appoints Alexandre Eleonore as director of manufacturing 170
6.2 Nov 19, 2019: Impella heart pumps associated with complications after stent procedure 170
6.3 Nov 19, 2019: Abiomed Medical Office completes review of Observational Analysis of Impella Presented at AHA 171
6.4 Nov 19, 2019: CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic 174
6.5 Nov 19, 2019: Improving the odds for patients with heart pumps 175
6.6 Nov 14, 2019: Clinical review demonstrates cost-effectiveness of Impella in high-risk PCI and Cardiogenic Shock 175
6.7 Nov 13, 2019: Micron Solutions reports 2019 third quarter results 178
7 Appendix 261
7.1 Methodology 261
7.2 About GlobalData 264
7.3 Contact Us 264
7.4 Disclaimer 264
List of Figure
List of Figures
Figure 1: Mechanical Circulatory Support Devices-Pipeline Products by Stage of Development 16
Figure 2: Mechanical Circulatory Support Devices-Pipeline Products by Segment 17
Figure 3: Mechanical Circulatory Support Devices-Pipeline Products by Territory 18
Figure 4: Mechanical Circulatory Support Devices-Pipeline Products by Regulatory Path 19
Figure 5: Mechanical Circulatory Support Devices-Pipeline Products by Estimated Approval Date 20
Figure 6: Mechanical Circulatory Support Devices-Ongoing Clinical Trials 21
List of Table
List of Tables
Table 1: Mechanical Circulatory Support Devices-Pipeline Products by Stage of Development 16
Table 2: Mechanical Circulatory Support Devices-Pipeline Products by Segment 17
Table 3: Mechanical Circulatory Support Devices-Pipeline Products by Territory 18
Table 4: Mechanical Circulatory Support Devices-Pipeline Products by Regulatory Path 19
Table 5: Mechanical Circulatory Support Devices-Pipeline Products by Estimated Approval Date 20
Table 6: Mechanical Circulatory Support Devices-Ongoing Clinical Trials 21
Table 7: Mechanical Circulatory Support Devices Companies-Pipeline Products by Stage of Development 22
Table 8: Mechanical Circulatory Support Devices-Pipeline Products by Stage of Development 25
Table 9: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 10: AbioCor II-Product Status 29
Table 11: AbioCor II-Product Description 30
Table 12: Impella BTR-Product Status 30
Table 13: Impella BTR-Product Description 30
Table 14: Impella ECP-Product Status 31
Table 15: Impella ECP-Product Description 31
Table 16: Next Generation Impella CP-STEMI-Product Status 31
Table 17: Next Generation Impella CP-STEMI-Product Description 32
Table 18: Abiomed Inc-Ongoing Clinical Trials Overview 33
Table 19: Next Generation Impella CP-STEMI-A Pivotal, Multi-center, Prospective Study of Impella CP System to Avoid the Development of Heart Failure 34
Table 20: Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 35
Table 21: CorAide Left Ventricular Assist System-Product Status 35
Table 22: CorAide Left Ventricular Assist System-Product Description 35
Table 23: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 24: PliCath HF-Product Status 36
Table 25: PliCath HF-Product Description 36
Table 26: BioVentrix Inc-Ongoing Clinical Trials Overview 37
Table 27: PliCath HF-Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 38
Table 28: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 39
Table 29: BiVACOR Device-Product Status 39
Table 30: BiVACOR Device-Product Description 39
Table 31: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 40
Table 32: Blood Pump-Product Status 40
Table 33: Blood Pump-Product Description 40
Table 34: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 35: Calon MiniVAD-Product Status 41
Table 36: Calon MiniVAD-Product Description 41
Table 37: CathVAD-Product Status 42
Table 38: CathVAD-Product Description 42
Table 39: MicroVAD-Product Status 42
Table 40: MicroVAD-Product Description 43
Table 41: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 44
Table 42: Pediatric pVAD-Product Status 44
Table 43: Pediatric pVAD-Product Description 44
Table 44: CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 45: CARDIAnove Pump-Product Status 45
Table 46: CARDIAnove Pump-Product Description 45
Table 47: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 46
Table 48: Artificial Heart-Product Status 46
Table 49: Artificial Heart-Product Description 47
Table 50: Carmat SAS-Ongoing Clinical Trials Overview 48
Table 51: Artificial Heart-Carmat Total Artificial Heart Early Feasibility Study 49
Table 52: Artificial Heart-Clinical Evaluation of the Carmat Total Artificial Heart for Patients with Advanced Heart Failure 49
Table 53: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 50
Table 54: Non-Blood Contacting Muscle Powered VAD-Product Status 50
Table 55: Non-Blood Contacting Muscle Powered VAD-Product Description 50
Table 56: tVAD-Heart Failure-Product Status 51
Table 57: tVAD-Heart Failure-Product Description 51
Table 58: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 52
Table 59: PediPump-Product Status 52
Table 60: PediPump-Product Description 52
Table 61: Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 53
Table 62: Continuous-Flow Total Artificial Heart-Product Status 53
Table 63: Continuous-Flow Total Artificial Heart-Product Description 53
Table 64: Pediatric Continuous-Flow Total Artificial Heart-Product Status 54
Table 65: Pediatric Continuous-Flow Total Artificial Heart-Product Description 54
Table 66: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 55
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.